CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
ChemGenex Pharmaceuticals Limited - ADR Company Snapshot
Business Description:
ChemGenex Pharmaceuticals Limited - ADR operates in the Commercial physical research sector. ChemGenex Pharmaceuticals Limited (ChemGenex) is an integrated biopharmaceutical development company with specialize in the discovery and the development of oncology drugs. As of June 30, 2010, ChemGenex Pharmaceuticals Inc. and ChemGenex Europe SAS were 100% owned by ChemGenex Pharmaceuticals Limited. ChemGenex focuses on developing targeted medicines for the treatment of cancer by identifying and targeting the genetic components of a range of cancer types. The Company has two molecules in clinical development and has progressed its lead compound, omacetaxine, to regulatory submission in Europe and the United States. The Company has submitted Omacetaxine to United States and European regulators for approval in chronic myeloid leukemia (CML) patients who have failed the tyrosine kinase inhibitor (TKI) imatinib and have the T315I point mutation. ChemGenex's other development stage molecule Quinamed, has completed phase IIa clinical trials in a range of solid cancers.
   
   
 
  Stock Performance Chart for ChemGenex Pharmaceuticals Limited - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (7/18/2011): 10.68
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
ChemGenex Pharmaceuticals Limited - ADR Key Data:
  Ticker: CXSP Country: AUSTRALIA
  Exchanges: OTC Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 271,662
(Year Ending Jan 2011).		 Employees: 19
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: June Shares Outstanding: N/A
  Share Type: Ordinary Closely Held Shares: N/A
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.